IONS: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/8ac14dff-7320-41a5-8099-fd324eebb4bd/","filing_uuid":"8ac14dff-7320-41a5-8099-fd324eebb4bd","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8ac14dff-7320-41a5-8099-fd324eebb4bd/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Beth Anne Cole","dt_posted":"2026-10-15T16:28:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2855 Gazelle Court","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Carlsbad","registrant_state":"CA","registrant_zip":"92010","registrant":{"id":401108715,"url":"https://lda.gov/api/v1/registrants/401108715/","house_registrant_id":56573,"name":"IONIS PHARMACEUTICALS, INC.","description":null,"address_1":"2855 Gazelle Court","address_2":null,"address_3":null,"address_4":null,"city":"Carlsbad","state":"CA","state_display":"California","zip":"92010","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 760-348-8517","dt_updated":"2026-07-19T12:32:47.660355-04:00"},"client":{"id":61063,"url":"https://lda.gov/api/v1/clients/61063/","client_id":61063,"name":"IONIS PHARMACEUTICALS, INC.","general_description":"Biotechnology company.","client_government_entity":null,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147257,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147257,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147257,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}